New bipartisan legislation would allow hemp-derived cannabidiol (CBD) to be marketed as a dietary supplement.
The bill, introduced Monday, gives the Food and Drug Administration the ability to include hemp CBD as a dietary supplement under the Federal Food, Drug and Cosmetic Act. It would also require a study and report from the U.S. Department of Agriculture on the regulatory and market barriers for hemp growers.
“The last two Farm Bills were landmark successes for hemp, but we are still very early in this process, and growers need regulatory certainty,” said House Agriculture Committee Chairman Collin Peterson in a press release. “This bill will allow FDA to regulate CBD that comes from hemp as a dietary supplement, providing a pathway forward for hemp-derived products.”
